Radiation recall dermatitis due to gemcitabine does not suggest the need to discontinue chemotherapy

Author： Lock Michael   Sinclair Kevin   Welch Stephen   Younus Jawaid   Salim Mohammad  

Publisher： Spandidos Publications

ISSN： 1792-1074

Source： Oncology Letters, Vol.2, Iss.1, 2011-01, pp. : 85-90

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gemcitabine-induced radiation recall dermatitis following whole pelvic radiation therapy

By Schwartz B.M.   Khuntia D.   Kennedy A.W.   Markman M.  

Gynecologic Oncology, Vol. 91, Iss. 2, 2003-11 ,pp. : 421-422

Elsevier

Access to resources Recommend Favorite

Pemetrexed-associated radiation recall dermatitis

By Khanfir Kaouthar   Anchisi Sandro  

Acta Oncologica, Vol. 47, Iss. 8, 2008-01 ,pp. : 1607-1608

Informa Healthcare

Access to resources Recommend Favorite

Myelopathy After Radiation Therapy and Chemotherapy with Capecitabine and Gemcitabine

By Barstis John   Black Alexander  

Cancer Investigation, Vol. 23, Iss. 7, 2005-10 ,pp. : 596-598

Informa Healthcare

Access to resources Recommend Favorite

Radiation-recall Dermatitis with Docetaxel: Establishment of a Requisite Radiation Threshold

By Yeo W.   Leung S.F.   Johnson P.J.  

European Journal of Cancer, Vol. 33, Iss. 4, 1997-04 ,pp. : 698-699

Elsevier

Access to resources Recommend Favorite

Radiation Recall Dermatitis After Pre-Sensitization With Pegylated Liposomal Doxorubicin

By Gzell Cecelia   Carroll Susan   Suchowerska Natalka   Beith Jane   Tan King   Scolyer Richard  

Cancer Investigation, Vol. 27, Iss. 4, 2009-05 ,pp. : 397-401

Informa Healthcare

Access to resources Recommend Favorite